AI assistant
Sending…
Lipocine Inc. — Director's Dealing 2022
Nov 8, 2022
35074_dirs_2022-11-08_6ed35b40-8921-4c2a-9a47-8845f78eba26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2022-11-01
Reporting Person: Nomikos George (Chief Medical Officer)
More from Lipocine Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Proxy Solicitation & Information Statement
2026
Apr 21
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Feb 18